Israeli Startup Leverages AI to Increase IVF Success Rates
Embryonics develops an algorithm that uses time-lapsed imaging to predict embryo implantation probability, aiming to reduce the number of costly IVF cycles women endure.
An Israeli startup called Embryonics uses artificial intelligence to improve the success rates of in vitro fertilization by predicting the implantation probability of embryos. The company trains its algorithm using time-lapsed imaging of developing embryos to bring more standardized diagnostic accuracy to the IVF process. Early pilot results show promising outcomes, with six out of eleven women currently experiencing successful pregnancies.
The global IVF market continues to expand rapidly as more women delay childbearing due to economic concerns, yet patients consistently face high costs and low odds of success per cycle. By accurately identifying the healthiest embryos, Embryonics aims to reduce the number of grueling and expensive IVF rounds that patients must endure. This approach offers significant hope for disrupting a multi-billion-dollar industry that has relied on the same core methods for decades.
Embryonics benefits from a highly experienced founding team that combines deep medical and technical expertise. The startup brings together an M.D. with an IVF research background, a former Apple machine learning engineer, and a serial founder who leads a prominent AI center. This blend of medical knowledge and advanced computational power drives the company's mission to revolutionize fertility treatments.